Cerity Partners LLC Igm Biosciences, Inc. Transaction History
Cerity Partners LLC
- $55.1 Billion
- Q2 2025
A detailed history of Cerity Partners LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 11,923 shares of IGMS stock, worth $15,499. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,923
Previous 13,106
9.03%
Holding current value
$15,499
Previous $15,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IGMS
# of Institutions
73Shares Held
15.3MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5.32 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.23 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.84 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.15 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY793KShares$1.03 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $37.7M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...